Literature DB >> 32301327

Heterogeneity in Conduction Underlies Obesity-Related Atrial Fibrillation Vulnerability.

Corina Schram-Serban1, Annejet Heida1, Maarten C Roos-Serote1, Paul Knops1, Charles Kik2, Bianca Brundel3,4, Ad J J C Bogers2, Natasja M S de Groot1.   

Abstract

BACKGROUND: Obese patients are more vulnerable to development of atrial fibrillation but pathophysiology underlying this relation is only partly understood. The aim of this study is to compare the severity and extensiveness of conduction disorders between obese patients and nonobese patients measured at a high-resolution scale.
METHODS: Patients (N=212) undergoing cardiac surgery (male:161, 63±11 years) underwent epicardial mapping of the right atrium, Bachmann bundle, and left atrium during sinus rhythm. Conduction delay (CD) was defined as interelectrode conduction time of 7 to 11 ms and conduction block (CB) as conduction time ≥12 ms. Prevalence of CD/CB, continuous CDCB (cCDCB), length of CD/CB/cCDCB lines, and severity of CB were analyzed.
RESULTS: In obese patients, the overall incidence of CD (3.1% versus 2.6%; P=0.002), CB (1.8% versus 1.2%; P<0.001), and cCDCB (2.6% versus 1.9%; P<0.001) was higher and CD (P=0.012) and cCDCB (P<0.001) lines are longer. There were more conduction disorders at Bachmann bundle and this area has a higher incidence of CD (4.4% versus 3.3%, P=0.002), CB (3.1% versus 1.6%, P<0.001), cCDCB (4.6% versus 2.7%, P<0.001) and longer CD (P<0.001) or cCDCB (P=0.017) lines. The severity of CB is also higher, particularly in the Bachmann bundle (P=0.008) and pulmonary vein (P=0.020) areas. In addition, obese patients have a higher incidence of early de-novo postoperative atrial fibrillation (P=0.003). Body mass index (P=0.037) and the overall amount of CB (P=0.012) were independent predictors for incidence of early postoperative atrial fibrillation.
CONCLUSIONS: Compared with nonobese patients, obese patients have higher incidences of conduction disorders, which are also more extensive and more severe. These differences in heterogeneity in conduction are already present during sinus rhythm and may explain the higher vulnerability to atrial fibrillation of obese patients.

Entities:  

Keywords:  atrial fibrillation; body mass index; cardiac electrophysiology; incidence; obesity

Year:  2020        PMID: 32301327     DOI: 10.1161/CIRCEP.119.008161

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  5 in total

1.  Premature atrial stimulation accentuates conduction abnormalities in cardiac surgery patients that develop postoperative atrial fibrillation.

Authors:  Muhammad S Khan; Matthias Lange; Ravi Ranjan; Vikas Sharma; Jason P Glotzbach; Craig Selzman; Derek J Dosdall
Journal:  J Electrocardiol       Date:  2021-09-10       Impact factor: 1.380

2.  Does conduction heterogeneity determine the supervulnerable period after atrial fibrillation?

Authors:  Annejet Heida; Willemijn F B van der Does; Mathijs S van Schie; Lianne N van Staveren; Yannick J H J Taverne; Ad J J C Bogers; Natasja M S de Groot
Journal:  Med Biol Eng Comput       Date:  2022-10-12       Impact factor: 3.079

Review 3.  Comprehensive evaluation of electrophysiological and 3D structural features of human atrial myocardium with insights on atrial fibrillation maintenance mechanisms.

Authors:  Aleksei V Mikhailov; Anuradha Kalyanasundaram; Ning Li; Shane S Scott; Esthela J Artiga; Megan M Subr; Jichao Zhao; Brian J Hansen; John D Hummel; Vadim V Fedorov
Journal:  J Mol Cell Cardiol       Date:  2020-10-29       Impact factor: 5.000

4.  Degree of Fibrosis in Human Atrial Tissue Is Not the Hallmark Driving AF.

Authors:  Kennedy S Ramos; Lisa Pool; Mathijs S van Schie; Leonoor F J M Wijdeveld; Willemijn F B van der Does; Luciënne Baks; H M Danish Sultan; Stan W van Wijk; Ad J J C Bogers; Sander Verheule; Natasja M S de Groot; Bianca J J M Brundel
Journal:  Cells       Date:  2022-01-26       Impact factor: 6.600

5.  Right atrial blood supply and complexity of induced atrial fibrillation: What's left?

Authors:  David R Van Wagoner
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.